NKGen Biotech's total assets for Q were $15.65M, a decrease of -4.09% from the previous quarter. NKGN total liabilities were $85.36M for the fiscal quarter, a 19.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.